Author:

Dr. Adriana Gudiño

Scientific Director of MER ROOT LAB, Mexico

Abstract

Cancer should not be understood solely as the autonomous proliferation of tumor cells, but rather as the cumulative consequence of endocrine, digestive, mitochondrial, and immunometabolic dysfunctions, accompanied by epigenetic deregulation. Between 2020 and 2024, a clinical multisystemic protocol was developed and applied, aimed at restoring the integral physiology of the organism without resorting to conventional cytotoxic strategies.

Protocol

The model included the strategic and personalized restitution of key hormones — such as estrogens, progesterone, or testosterone, depending on the individual physiological profile— in order to reactivate regenerative pathways, normalize microcirculation, recover collagen synthesis, and modulate cellular inflammation. The approach was complemented with hepatorenal detoxification, digestive regulation, stabilization of physiological pH, reversal of cellular senescence, and precision nutrigenomic supplementation.

In advanced stages, highly specific nutraceutical formulations, exosomes, and precise doses of mesenchymal stem cells in the order of millions were integrated, with the aim of repairing damaged tissues, stimulating regeneration, and enhancing immunomodulation.

Results

Patients treated under this scheme showed decreases in tumor biomarkers, improvements in tissue oxygenation and vitality, normalization of sleep, recovery of digestive function, and stabilization of neuroendocrine parameters. In some cases, pain reduction, improved mobility, and strengthening of the immune response were documented, resulting in a better quality of life.

Conclusion

The multisystemic physiological intervention, based on adaptive hormonal restoration, digestive and mitochondrial regulation, and cellular epigenetic modulation, represents an integrative and specific clinical alternative. Its objective is not the indiscriminate destruction of cells, but rather the hierarchical recovery of the organism’s original physiological function. By addressing the root of the imbalance, a more favorable scenario for remission and functional recovery in oncological patients can be achieved.

More information here: merrootlab.com/

Media Contact
Company Name: Adriana Gudiño
Contact Person: Press Office
Email: Send Email
Country: United States
Website: https://merrootlab.com/